Effectiveness of Cetuximab in Combination with Concurrent Chemoradiotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma: A 1:2 Propensity Score-matched Analysis

Background: This study aimed to compare concurrent chemoradiotherapy (CCRT) plus cetuximab (C) with CCRT alone in locoregionally advanced nasopharyngeal carcinoma(NPC). Methods: A total of 682 locoregionally advanced NPC patients who had undergone chemoradiotherapy with or without cetuximab were inc...

Descripción completa

Detalles Bibliográficos
Autores principales: Wu, Li-Rong, Zhu, Huan-feng, Xu, Jianhua, Jiang, Xue-song, Yin, Li, Jiang, Ning, Zong, Dan, Wang, Fei-jiang, Huang, Sheng-fu, Bian, Xiu-hua, Wu, Jian-feng, Song, Dan, Guo, Wen-jie, Liu, Ju-Ying, He, Xia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2018
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950594/
https://www.ncbi.nlm.nih.gov/pubmed/29760803
http://dx.doi.org/10.7150/jca.23994

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5950594/
https://www.ncbi.nlm.nih.gov/pubmed/29760803
http://dx.doi.org/10.7150/jca.23994

Ejemplares similares